'Part of re­cov­ery is aware­ness': Pan­dem­ic casts harsh spot­light on in­dus­try-wide lack of di­ver­si­ty in clin­i­cal tri­als

Mod­er­na emerged as an ear­ly leader in the race for a vac­cine to stop Covid-19 in its tracks. The Cam­bridge, Mass­a­chu­setts-based biotech bound­ed through de­vel­op­ment …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER